Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Mulloy

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Pharmaceuticals (Basel, Switzerland)|March 3, 2018
Glycosaminoglycans and ProteoglycansVitor H Pomin, Barbara Mulloy
Molecules (Basel, Switzerland)|May 5, 2017
Heparin, Heparan Sulphate and the TGF-β Cytokine SuperfamilyChris C Rider, Barbara Mulloy
Current Opinion in Structural Biology|June 4, 2015
Current structural biology of the heparin interactomeVitor H Pomin, Barbara Mulloy
Micron (Oxford, England : 1993)|January 16, 2007
Consideration of the three-dimensional structure of core shells (capsids) in spherical retrovirusesMilan V Nermut, Barbara Mulloy
Biochemical Society Transactions|September 25, 2010
Structural glycobiology and human healthBarbara Mulloy, Anthony P Corfield
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Heparin, Heparan Sulphate and Sepsis: Potential New Options for TreatmentJohn Hogwood, Elaine Gray, Barbara Mulloy
Pharmaceuticals (Basel, Switzerland)|July 4, 2017
Precipitation and Neutralization of Heparin from Different Sources by Protamine SulfateJohn Hogwood, Barbara Mulloy, Elaine Gray
Handbook of Experimental Pharmacology|May 9, 2012
The anticoagulant and antithrombotic mechanisms of heparinElaine Gray, John Hogwood, Barbara Mulloy
Thrombosis and Haemostasis|May 2, 2008
Heparin and low-molecular-weight heparinElaine Gray, Barbara Mulloy, Trevor W Barrowcliffe
Glycobiology|August 4, 2007
The binding of human betacellulin to heparin, heparan sulfate and related polysaccharidesRosemary S Mummery, Barbara Mulloy, Christopher C Rider
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Pharmaceuticals (Basel, Switzerland)|March 3, 2018
Glycosaminoglycans and ProteoglycansVitor H Pomin, Barbara Mulloy
Molecules (Basel, Switzerland)|May 5, 2017
Heparin, Heparan Sulphate and the TGF-β Cytokine SuperfamilyChris C Rider, Barbara Mulloy
Current Opinion in Structural Biology|June 4, 2015
Current structural biology of the heparin interactomeVitor H Pomin, Barbara Mulloy
Micron (Oxford, England : 1993)|January 16, 2007
Consideration of the three-dimensional structure of core shells (capsids) in spherical retrovirusesMilan V Nermut, Barbara Mulloy
Biochemical Society Transactions|September 25, 2010
Structural glycobiology and human healthBarbara Mulloy, Anthony P Corfield
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Heparin, Heparan Sulphate and Sepsis: Potential New Options for TreatmentJohn Hogwood, Elaine Gray, Barbara Mulloy
Pharmaceuticals (Basel, Switzerland)|July 4, 2017
Precipitation and Neutralization of Heparin from Different Sources by Protamine SulfateJohn Hogwood, Barbara Mulloy, Elaine Gray
Handbook of Experimental Pharmacology|May 9, 2012
The anticoagulant and antithrombotic mechanisms of heparinElaine Gray, John Hogwood, Barbara Mulloy
Thrombosis and Haemostasis|May 2, 2008
Heparin and low-molecular-weight heparinElaine Gray, Barbara Mulloy, Trevor W Barrowcliffe
Glycobiology|August 4, 2007
The binding of human betacellulin to heparin, heparan sulfate and related polysaccharidesRosemary S Mummery, Barbara Mulloy, Christopher C Rider
Pageof 10